Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
Eighty years after the introduction of the first antituberculosis (TB) drug, the treatment of drug-susceptible TB remains very cumbersome, requiring the use of four drugs (isoniazid, rifampicin, ethambutol and pyrazinamide) for two months followed by four months on isoniazid and rifampicin. Two of t...
Main Author: | Catherine Vilchèze |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/7/2278 |
Similar Items
-
Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01) -
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
by: Hans Carolus, et al.
Published: (2020-11-01) -
Editorial: Drug-resistant Mycobacterium tuberculosis
by: Helena I. M. Boshoff, et al.
Published: (2023-05-01) -
The Progress towards Novel Herbicide Modes of Action and Targeted Herbicide Development
by: Bo He, et al.
Published: (2022-11-01) -
Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
by: Vaishali P. Waman, et al.
Published: (2019-01-01)